OPKO Health (OPK) Stock Price, Quote, News & History | Benzinga

SPY764.70−1.09%QQQ711.77−1.85%BTC/USD81,759.39−2.69%DIA523.95−0.71%GLD374.20−1.25%TLT80.68+0.55%

OPKO Health Inc (OPK) Stock Price, Quote, News & History

OPKNASDAQ

Trade with Public

Trade with Public

$1.60

-0.06-3.61%

Last update: Oct 22, 5:29 AM

$1.59

-0.0692-4.17%

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

-

Close

$1.60

Volume / Avg.

19.89K / 4.21M

Day Range

- - -

52 Wk Range

0.98 - 1.77

Market Cap

$1.19B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

59

Short Interest

8.57%

Days to Cover

14.94

Recent OPKO Health, Inc. News

Myriad Genetics Offloads Struggling Prenatal Unit for $210 Million to Labcorp

Labcorp will purchase Myriad Genetics' prenatal testing business for $210 million in cash, projecting $160 million in year-one revenue.

Vandana Singh

Ladder Capital Posts Upbeat Q3 Earnings, Joins Alcoa, Hyster-Yale And Other Big Stocks Moving Higher On Friday

U.S. stocks were mixed; Ladder Capital surged after beating Q3 estimates. Alcoa and other stocks also gained, led by Strata Critical Medical’s 7.5% rise.

Avi Kapoor

Crude Oil Moves Higher; Charles Schwab Shares Fall After Q3 Results

U.S. stocks mixed: Dow gained 450+ points, S&P rose, Nasdaq slipped. Healthcare led gains; energy fell. Oil and gold climbed, Asian markets mostly

Avi Kapoor

OPKO Health Sheds Diagnostics Businesses in Major Labcorp Deal

OPKO Health jumps 18% and Labcorp trades higher as LH acquires BioReference Health assets in an $872M deal.

Vandana Singh

Penske Automotive, OPKO Health, Ericsson And Other Big Stocks Moving Higher On Thursday

U.S. stocks mixed; Dow up ~200 points. Penske Automotive surged on a $16.3B go-private deal, while OPKO, Ericsson and others rallied.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-123.38M

Investing Cash Flow (TTM)

206.34M

Financing Cash Flow (TTM)

-52.73M

Free Cash Flow (TTM)

-134.02M

Capital Expenditure (TTM)

-10.64M

Net Change in Cash (TTM)

30.23M

Analyst Trends and Forecast

1

Apr

2

Oct

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.9

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$1.29B

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

2.12

PB Ratio (TTM)

1.01

Earnings Yield % (TTM)

-4.38%

Earnings Yield % (FWD)

-16.25%

EV / EBITDA (TTM)

23.53

Price / EBITDA (TTM)

22.72

Price / Free Cash Flow (TTM)

-

Book Value / Share

$1.59

Company Debt

Total Debt

$349.05M

LT Debt

$338.49M

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-$41.41M

Total Cash

$300.76M

Debt to Equity

0.34

Issuance of Debt (TTM)

-$8.38M

Repayment of Debt (TTM)

-$40.74M